Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Details
Publication Year 2024-04-01,Volume 118,Issue #5,Page 1152-1158
Journal Title
International Journal of Radiation Oncology, Biology, Physics
Publication Type
Commentary
Publisher
Elsevier
Keywords
Humans; *Receptors, Chimeric Antigen; *Lymphoma, Large B-Cell, Diffuse/radiotherapy; Immunotherapy, Adoptive/adverse effects; *Lymphoma, Non-Hodgkin; Cell- and Tissue-Based Therapy
Department(s)
Radiation Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-04-16 01:10:02
Last Modified: 2024-04-16 01:23:13

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙